Elite in Chronic Obstructive Pulmonary Disease (COPD)

Alberto A. Papi

Ferrara, IT 
Elite in Chronic Obstructive Pulmonary Disease (COPD)
Ferrara, IT 
OverviewLocationsClinical Research

Overview

Alberto Papi practices in Ferrara, Italy. Mr. Papi is rated as an Elite expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Chronic Eosinophilic Pneumonia, and Endoscopy.

His clinical research consists of co-authoring 406 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 188 articles in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Ferrara, Italy
Other Locations
University of Ferrara & St. Anna University Hospital, Ferrara
Fe, Italy
Anna, Italy
Milan, Italy
Ferrera, Italy
Via Aldo Moro 8, Cona, 44124, Italy
Bologna, Italy
Perugia, 06100, Italy
Chiesi Farmaceutici
Parma, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: RSVPreF3
Study Phase: Phase 3
Assessment of Adequacy and Characteristics Molecular of the Sample Obtained by Fine-needle Aspiration (FNA) Cytology Lung, Mounted With Thin Prep Compared to the Conventional Smear, in the Diagnosis of Lung Cancer.
Assessment of Adequacy and Characteristics Molecular of the Sample Obtained by Fine-needle Aspiration (FNA) Cytology Lung, Mounted With Thin Prep Compared to the Conventional Smear, in the Diagnosis of Lung Cancer.
Enrollment Status: Completed
Publish Date: May 03, 2018
View 1 Less Clinical Trial

406 Total Publications

The ROME COPD Exacerbation Proposal Works! Time to Move Forward.
The ROME COPD Exacerbation Proposal Works! Time to Move Forward.
Journal: American journal of respiratory and critical care medicine
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Papi's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile